Search research articles
Contact Us
Filters
Showing results (101-110 of 110) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 110 results.
ESMO Open
|
March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials
L Arenare, R Di Liello, P De Placido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2015
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
J Vansteenkiste, F Barlesi, C F Waller, et al.
British Journal of Cancer
|
November 24, 2004
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study
C Gridelli, C Gallo, M Di Maio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2013
A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)
H J M Groen, M A Socinski, F Grossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1996
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.)
C Gridelli, F Perrone, S Palmeri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project
L Crinò, G V Scagliotti, S Ricci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 24, 2011
Third CECOG consensus on the systemic treatment of non-small-cell lung cancer
T Brodowicz, T Ciuleanu, J Crawford, et al.
British Journal of Cancer
|
May 27, 2004
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer
M Di Maio, C Gridelli, C Gallo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 18, 2004
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
T Le Chevalier, G Scagliotti, R Natale, et al.
British Journal of Cancer
|
September 11, 2003
Supportive care in patients with advanced non-small-cell lung cancer
M Di Maio, F Perrone, C Gallo, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 110) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 110 results.
ESMO Open
|
March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials
L Arenare, R Di Liello, P De Placido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2015
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
J Vansteenkiste, F Barlesi, C F Waller, et al.
British Journal of Cancer
|
November 24, 2004
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study
C Gridelli, C Gallo, M Di Maio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2013
A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)
H J M Groen, M A Socinski, F Grossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1996
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.)
C Gridelli, F Perrone, S Palmeri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project
L Crinò, G V Scagliotti, S Ricci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 24, 2011
Third CECOG consensus on the systemic treatment of non-small-cell lung cancer
T Brodowicz, T Ciuleanu, J Crawford, et al.
British Journal of Cancer
|
May 27, 2004
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer
M Di Maio, C Gridelli, C Gallo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 18, 2004
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
T Le Chevalier, G Scagliotti, R Natale, et al.
British Journal of Cancer
|
September 11, 2003
Supportive care in patients with advanced non-small-cell lung cancer
M Di Maio, F Perrone, C Gallo, et al.
Page
of 11